Templin M V, Constan A A, Wolf D C, Wong B A, Butterworth B E
Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709-2137, USA.
Carcinogenesis. 1998 Jan;19(1):187-93. doi: 10.1093/carcin/19.1.187.
It has been reported that chloroform administered to BDF1 mice by inhalation for 2 years at concentrations of 5, 30 or 90 p.p.m. for 6 h/day, 5 days/week induced an increase in renal cell tumors in male but not female mice exposed to the doses of 30 and 90 p.p.m. A small increase in liver tumors was statistically significant in the female mice at 90 p.p.m. if the incidences of carcinomas and adenomas were combined. Because chloroform is not a DNA reactive mutagen, a 13-week time-course and dose-response study was conducted under conditions of the original bioassay to examine whether regenerative cell proliferation was an underlying mechanism of carcinogenesis. Mice were given bromodeoxyuridine via infusion during the last 3.5 days prior to necropsy to label cells in S-phase. Chloroform induced pathology and regenerative cell proliferation, measured as the labeling index (LI, percentage of cells in S-phase), were assessed microscopically and immunohistochemically. Male mice exposed to 30 and 90 p.p.m. exhibited a dose-dependent increase in regenerating tubules within the renal cortex and up to a 31-fold increase in LI. No renal lesions or increased LI were observed in females. Increased centrilobular to midzonal hepatocyte degeneration and vacuolation and a 7-fold increase over controls in the hepatocyte LI were observed in the female mice at 90 p.p.m. at 13 weeks. Males exhibited similar pathology, but the increase in LI was not sustained. The observed correlations between cytolethality and regenerative cell proliferation with tumor formation supports extensive evidence that chloroform induces cancer via a non-genotoxic-cytotoxic mode of action. A concentration of 5 p.p.m. is the no-observed-adverse-effect level for nephrotoxicity, cell proliferation and cancer. An appropriate safety factor applied to this value is a straightforward approach to cancer risk assessment that is consistent with the mode of action of chloroform.
据报道,将BDF1小鼠暴露于浓度为5、30或90 ppm的氯仿环境中,每天吸入6小时,每周5天,持续2年,结果发现,暴露于30 ppm和90 ppm剂量的雄性小鼠肾细胞肿瘤有所增加,而雌性小鼠未出现这种情况。如果将癌和腺瘤的发病率合并计算,90 ppm剂量下的雌性小鼠肝脏肿瘤有小幅增加,且具有统计学意义。由于氯仿不是一种具有DNA反应性的诱变剂,因此在原始生物测定条件下进行了一项为期13周的时间进程和剂量反应研究,以检查再生细胞增殖是否是致癌的潜在机制。在尸检前的最后3.5天,通过静脉输注给小鼠注射溴脱氧尿苷,以标记处于S期的细胞。通过显微镜和免疫组织化学方法评估氯仿诱导的病理学变化以及以标记指数(LI,即处于S期的细胞百分比)衡量的再生细胞增殖情况。暴露于30 ppm和90 ppm剂量的雄性小鼠肾皮质内再生肾小管呈剂量依赖性增加,LI增加高达31倍。雌性小鼠未观察到肾脏病变或LI增加。在13周时,90 ppm剂量下的雌性小鼠中央小叶至中区肝细胞变性和空泡化增加,肝细胞LI比对照组增加7倍。雄性小鼠表现出类似的病理学变化,但LI的增加未持续。观察到的细胞毒性和再生细胞增殖与肿瘤形成之间的相关性支持了大量证据,即氯仿通过非遗传毒性-细胞毒性作用模式诱导癌症。5 ppm的浓度是未观察到肾毒性、细胞增殖和癌症不良反应的水平。将适当的安全系数应用于此值是一种直接的癌症风险评估方法,与氯仿的作用模式一致。